The Stanford Headache & Facial Pain Program Clinical Trials

Interventional, randomized, double-blind, parallel-group, placebo-controlled delayed-start study to evaluate the efficacy and safety of eptinezumab in patients with episodic Cluster Headache (Alleviate)
PI: Addie Peretz, MD
NCT04688775
Study Status: Enrolling
Contact: neurotrials@stanford.edu

Sunstar: The Stanford Neuroscience Headache Biorepository
PI: Robert Cowan, MD, FAAN
NCT03231241
Study Status: Enrolling
Contact: neurotrials@stanford.edu

Efficacy of ‘Green Glasses’ to Reduce Headache Symptoms in Individuals with Migraine Disorders
PI: Robert Cowan, MD, FAAN
Study Status: Not Yet Enrolling

A prospective, multi-centre, randomized, double-blind, sham-controlled, parallel-group, group-sequential study to investigate safety and effectiveness of the Rehaler partial rebreathing device, in adults suffering from migraine with aura: PAREMA1
PI: Robert Cowan, MD, FAAN
Study Status: Not Yet Enrolling